Literature DB >> 21837876

Antimicrobial resistance patterns in outpatient urinary tract infections--the constant need to revise prescribing habits.

Fredricka J Bosch1, Cloete van Vuuren, Gina Joubert.   

Abstract

BACKGROUND: There is a global emergence of resistance against commonly prescribed antibiotics. Empirical antibiotic prescribing should be guided by local antimicrobial susceptibility patterns. AIM: To dentify organisms and determine antibiotic susceptibility in urinary tract infections (UTIs) at 3 Military Hospital, Bloemfontein.
METHODS: All urine samples collected during 2008 were analysed. The first positive urine culture per patient collected from the casualty, gynaecology, internal medicine and surgical outpatient departments were included. Only adult patients (> 12 years old) were included. Prior use of antibiotics and underlying conditions were determined from electronic and paper-based patient and pharmacy records.
RESULTS: Positive cultures (N = 65) were divided into uncomplicated (N = 28) and complicated (N = 37) UTIs. Escherichia coli (E. coli) was the most common uropathogen in uncomplicated (75%) and complicated (59%) UTIs. In uncomplicated UTIs, trimethoprim-sulfamethoxazole (TMP-SMX) (54%) and amnoxicillin (46%) had the highest rates of resistance. Nitrofurantoin and ciprofloxacin had sensitivity rates of 89%. Co-amoxdclav was most commonly prescribed (36%). In complicated UTIS, TMP-SMX (68%) and amoxicillin (65%) had the highest resistance rates, followed by ciprofloxacin (41%). Nitrofurantoin had a sensitivity rate of 73%. Ciprofloxacin was prescribed most often (35%). All E. coli UTI isolates were sensitive to nitrofurantoin.
CONCLUSION: E. coli remains the most common uropathogen. TMP-SMX and amoxicillin are of no value in this population with UTIs. Uncomplicated UTIs can be treated effectively with nitrofurantoin; this will lead to cost savings and sparing quinolones as a class of antibiotics known to induce resistance. In this setting, ciprofloxacin should not be used empirically for complicated UTIs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21837876     DOI: 10.7196/samj.4346

Source DB:  PubMed          Journal:  S Afr Med J


  7 in total

1.  Antibiotic prescription by general practitioners for urinary tract infections in outpatients.

Authors:  E Denes; J Prouzergue; S Ducroix-Roubertou; C Aupetit; P Weinbreck
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-22       Impact factor: 3.267

2.  Foodborne urinary tract infections: a new paradigm for antimicrobial-resistant foodborne illness.

Authors:  Lora Nordstrom; Cindy M Liu; Lance B Price
Journal:  Front Microbiol       Date:  2013-03-06       Impact factor: 5.640

3.  Microbiology of urinary tract infections in Gaborone, Botswana.

Authors:  Andrew J Renuart; David M Goldfarb; Margaret Mokomane; Ephraim O Tawanana; Mohan Narasimhamurthy; Andrew P Steenhoff; Jonathan A Silverman
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

4.  Antibiotic resistance patterns of bacteria causing urinary tract infections in the elderly living in nursing homes versus the elderly living at home: an observational study.

Authors:  Mark Fagan; Morten Lindbæk; Nils Grude; Harald Reiso; Maria Romøren; Dagfinn Skaare; Dag Berild
Journal:  BMC Geriatr       Date:  2015-08-04       Impact factor: 3.921

5.  Susceptibility pattern of uropathogens to ciprofloxacin at the Ghana police hospital.

Authors:  Daniel Kwame Afriyie; Martha Gyansa-Lutterodt; Seth Kwabena Amponsah; George Asare; Vanessa Wiredu; Edem Wormenor; Kwasi Agyei Bugyei
Journal:  Pan Afr Med J       Date:  2015-10-01

6.  Antimicrobial susceptibility profile of uropathogens in Maluti Adventist Hospital patients, 2011.

Authors:  Phillip Mubanga; Wilhelm J Steinberg; Francois C Van Rooyen
Journal:  Afr J Prim Health Care Fam Med       Date:  2015-05-12

7.  Antibiotic-Resistant Pathogenic Escherichia Coli Isolated from Rooftop Rainwater-Harvesting Tanks in the Eastern Cape, South Africa.

Authors:  Mokaba Shirley Malema; Akebe Luther King Abia; Roman Tandlich; Bonga Zuma; Jean-Marc Mwenge Kahinda; Eunice Ubomba-Jaswa
Journal:  Int J Environ Res Public Health       Date:  2018-05-01       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.